Literature DB >> 24973941

Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.

Hirotake Komatsu1, Shinichi Egawa, Fuyuhiko Motoi, Takanori Morikawa, Naoaki Sakata, Takeshi Naitoh, Yu Katayose, Kazuyuki Ishida, Michiaki Unno.   

Abstract

PURPOSE: Adenosquamous carcinoma of the pancreas is a rare subtype of pancreatic cancer. We herein describe the clinicopathological features of surgically resected cases of adenosquamous carcinoma of the pancreas.
METHODS: From 2001 to 2011, 132 patients underwent R0 resection for Stage IIA or IIB pancreatic cancer. The survival rate, pathological features and recurrence status were reviewed.
RESULTS: Out of 132 patients, 121 patients had tubular adenocarcinoma, and only seven had adenosquamous carcinoma (ASC). The incidence of ASC increased with the tumor size. The overall survival and disease-free survival periods of the patients with ASC were significantly shorter than those of patients with tubular adenocarcinoma (p = 0.0153 and p = 0.0045). The histological findings revealed more marked venous invasion in ASC compared to tubular adenocarcinoma (G1, G2 and G3). The proportion of v3 cases, which denotes the most severe venous invasion, was 31.3 % in G1, 47.3 % in G2, 60.0 % in G3 and 71.4 % in ASC cases, respectively. Other factors, including lymphatic and nerve invasion, were not correlated with the histological subtypes. The incidence of ASC was 11.1 % in the tumors more than 6 cm in diameter, and 0 % in those less than 2 cm in diameter.
CONCLUSIONS: We revealed that adenosquamous carcinoma of the pancreas is associated with a poor outcome, and also clarified its clinicopathological features.

Entities:  

Mesh:

Year:  2014        PMID: 24973941     DOI: 10.1007/s00595-014-0934-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  31 in total

1.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

2.  Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma.

Authors:  A Sternberg; M Amar; R Alfici; G Groisman
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

3.  Adenosquamous carcinoma of the colon, rectum, and anus: epidemiology, distribution, and survival characteristics.

Authors:  B Cagir; M W Nagy; A Topham; J Rakinic; R D Fry
Journal:  Dis Colon Rectum       Date:  1999-02       Impact factor: 4.585

4.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Authors:  Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

5.  Adenosquamous carcinoma of the pancreas: cytologic features in 14 cases.

Authors:  Aliyah Rahemtullah; Joseph Misdraji; Martha B Pitman
Journal:  Cancer       Date:  2003-12-25       Impact factor: 6.860

6.  Pancreatic Cancer Registry in Japan: 20 years of experience.

Authors:  Seiki Matsuno; Shinichi Egawa; Shoji Fukuyama; Fuyuhiko Motoi; Makoto Sunamura; Shuji Isaji; Toshihide Imaizumi; Shuichi Okada; Hiroyuki Kato; Kouichi Suda; Akimasa Nakao; Takehisa Hiraoka; Ryo Hosotani; Kazunori Takeda
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

Review 7.  Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

Authors:  Kristell Bastide; Nicolas Ugolin; Céline Levalois; Jean-François Bernaudin; Sylvie Chevillard
Journal:  Lung Cancer       Date:  2009-12-08       Impact factor: 5.705

8.  Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas.

Authors:  K Motojima; T Tomioka; N Kohara; T Tsunoda; T Kanematsu
Journal:  J Surg Oncol       Date:  1992-01       Impact factor: 3.454

9.  Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.

Authors:  Rory L Smoot; Lizhi Zhang; Thomas J Sebo; Florencia G Que
Journal:  J Am Coll Surg       Date:  2008-05-15       Impact factor: 6.113

10.  Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Authors:  Xin Yi; John M Luk; Nikki P Lee; Jirun Peng; Xisheng Leng; Xin-Yuan Guan; George K Lau; Laura Beretta; Sheung-Tat Fan
Journal:  Mol Cell Proteomics       Date:  2007-10-14       Impact factor: 5.911

View more
  6 in total

1.  Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.

Authors:  Hideo Tomihara; Hidetoshi Eguchi; Daisaku Yamada; Kunihito Gotoh; Koichi Kawamoto; Hiroshi Wada; Tadafumi Asaoka; Takehiro Noda; Yutaka Takeda; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2016-09-01       Impact factor: 2.549

2.  Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database.

Authors:  Yuan Fang; Ning Pu; Lei Zhang; Wenchuan Wu; Wenhui Lou
Journal:  Ann Transl Med       Date:  2019-10

Review 3.  Adenosquamous carcinoma of the ampulla of Vater: a case report and literature review.

Authors:  Sojun Hoshimoto; Koichi Aiura; Masaya Shito; Toshihiro Kakefuda; Hitoshi Sugiura
Journal:  World J Surg Oncol       Date:  2015-09-29       Impact factor: 2.754

4.  Impact of resection margins on long-term survival after pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Xiang-Long Tan; Yuan-Xing Gao; Zi-Zheng Wang; Qu Liu; Zhi-Ming Zhao
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

Review 5.  Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.

Authors:  Chiara Bazzichetto; Claudio Luchini; Fabiana Conciatori; Vanja Vaccaro; Ilaria Di Cello; Paola Mattiolo; Italia Falcone; Gianluigi Ferretti; Aldo Scarpa; Francesco Cognetti; Michele Milella
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

Review 6.  Prognostic and predictive factors in pancreatic cancer.

Authors:  Emanuela Dell'Aquila; Claudia Angela Maria Fulgenzi; Alessandro Minelli; Fabrizio Citarella; Marco Stellato; Francesco Pantano; Marco Russano; Maria Concetta Cursano; Andrea Napolitano; Tea Zeppola; Bruno Vincenzi; Giuseppe Tonini; Daniele Santini
Journal:  Oncotarget       Date:  2020-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.